Search results
Results from the WOW.Com Content Network
Under current OPTN/ONUS guidelines, patients with cirrhosis and HCC who meet these criteria may be considered for transplantation. [2] Depending on the treatment algorithm, additional factors such as advanced liver disease (as classified by Child-Pugh score) or evidence of portal hypertension may also affect suitability for transplantation.
Hepatocellular carcinoma (HCC [1]) is the most common type of primary liver cancer in adults and is currently the most common cause of death in people with cirrhosis. [2] HCC is the third leading cause of cancer-related deaths worldwide. [3]
[2] [3] For a physician, this score is helpful in deciding how aggressively to treat a condition. It is one of the most widely used scoring system for comorbidities. [ 4 ] The index was developed by Mary Charlson and colleagues in 1987, but the methodology has been adapted several times since then based on the findings of additional studies. [ 5 ]
The Liver Imaging Reporting and Data System (aka LI-RADS) is a quality assurance tool created and trademarked by the American College of Radiology in 2011 to standardize the reporting and data collection of CT and MR imaging patients at risk for hepatocellular carcinoma (HCC), or primary cancer of the liver cells. [1]
Discover the best free online games at AOL.com - Play board, card, casino, puzzle and many more online games while chatting with others in real-time.
A 2003 study of Medicare managed care plans determined that plan-level health outcomes were associated with HEDIS measures. [ 12 ] An "Acute Outpatient Depression Indicator" score based on a HEDIS measure predicted improvement in depression severity in one 2005 study.
WASHINGTON (Reuters) -The U.S. Supreme Court agreed on Friday to decide the legality of a key component of the Affordable Care Act that effectively gives a task force established under the ...
Image source: The Motley Fool. AstraZeneca Plc (NASDAQ: AZN) Q4 2024 Earnings Call Feb 06, 2025, 6:00 a.m. ET. Contents: Prepared Remarks. Questions and Answers. Call Participants